Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1244]
News [2385]
Articles [91]
Editorials [4]
Conferences [117]
elearning [25]
PARP inhibitors and their side effects in solid tumour therapy
Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA
PARP inhibitors and their side effects in solid tumour therapy ( Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA )
8 May 2019
Cancer immunotherapy for the advanced practice nurse
Krista Rubin - Massachusetts General Hospital Cancer Center, Boston, USA
Cancer immunotherapy for the advanced practice nurse ( Krista Rubin - Massachusetts General Hospital Cancer Center, Boston, USA )
8 May 2019
Challenges to Jordanian Muslim men with prostate cancer
Abdulmalik Hasanain - Victoria University of Wellington, Wellington, New Zealand
Challenges to Jordanian Muslim men with prostate cancer ( Abdulmalik Hasanain - Victoria University of Wellington, Wellington, New Zealand )
8 May 2019
Checkpoint inhibitor induced Guillain-Barré syndrome
Jessica Edwards - The Ohio State University James Cancer Hospital, Ohio, USA
Checkpoint inhibitor induced Guillain-Barré syndrome ( Jessica Edwards - The Ohio State University James Cancer Hospital, Ohio, USA )
8 May 2019
Managing the side effects of CAR T-cell therapy
Misty Lamprecht - The Ohio State University James Cancer Hospital, Ohio, USA
Managing the side effects of CAR T-cell therapy ( Misty Lamprecht - The Ohio State University James Cancer Hospital, Ohio, USA )
8 May 2019
Role of radiation therapy with immunotherapy: Nurse’s perspective
Annette Quinn - University of Pittsburgh, Pittsburgh, USA
Role of radiation therapy with immunotherapy: Nurse’s perspective ( Annette Quinn - University of Pittsburgh, Pittsburgh, USA )
8 May 2019
The WIN symposium 2019
Prof Razelle Kurzrock - University of California San Diego, San Diego, USA
The WIN symposium 2019 ( Prof Razelle Kurzrock - University of California San Diego, San Diego, USA )
25 Apr 2019
An overview of the WIN consortium
Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical...
An overview of the WIN consortium ( Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA )
25 Apr 2019
Making oncology global with the WIN consortium
Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Making oncology global with the WIN consortium ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
25 Apr 2019
The translational element of the WIN consortium
Dr Brian Leyland-Jones - WIN Head of Fundraising Committee
The translational element of the WIN consortium ( Dr Brian Leyland-Jones - WIN Head of Fundraising Committee )
25 Apr 2019
How the WIN consortium achieves its goals
Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA
How the WIN consortium achieves its goals ( Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA )
25 Apr 2019
Latest data from KEYNOTE 42: Pembrolizumab vs chemotherapy in treatment-naive...
Prof Tony Mok - Chinese University of Hong Kong, Hong Kong
Latest data from KEYNOTE 42: Pembrolizumab vs chemotherapy in treatment-naive patients (pts) with PD-L1 advanced NSCLC ( Prof Tony Mok - Chinese University of Hong Kong, Hong Kong )
18 Apr 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation